Analysis of Azathioprine Metabolites in Autoimmune Hepatitis Patient Blood—Method Development and Validation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011233 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Andrea Guba und 5 weiteren Autor:innen. Beteiligte Einrichtung: Proteomics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, 4032 Debrecen…. Hauptthemen laut MEDLINE: Azathioprine, Hepatitis, Autoimmune, Thioguanine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union and the Ministry of Hungary.
Abstract (Originalsprache)
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease treated by steroids and immunomodulator thiopurine drugs such as azathioprine (AZA). AZA is metabolized in the human body into bioactive forms such as 6-thioguanine (6-TG) and 6-methyl-mercaptopurine (6-MMP). Monitoring the levels of bioactive AZA metabolites is very important for proper treatment of patients. In this study, our aim was to develop and validate a fast and sensitive ultra-high performance liquid chromatography–mass spectrometry (UHPLC–MS) method for the analysis of 6-TG and 6-MMP from blood samples of patients with AIH to monitor the level of these bioactive metabolites. The detection and quantification of the analytes was carried out by Selected Reaction Monitoring (SRM)-based targeted mass spectrometry. The method was validated according to the EMA guidelines. Blood samples from patients with AIH treated with AZA were analysed with the developed method. The method was successfully validated with appropriate accuracy and precision for the target biomolecules and their concentration in the samples from patients with AIH was determined. The developed and validated UHPLC–MS method enables the fast and precise analysis of AZA metabolites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Proteomics Core Facility, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.
- Metabolomics Research Group, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.
- Doctoral School of Molecular Cell and Immune Biology, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.
- Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
- Kálmán Laki Doctoral School, University of Debrecen, Egyetem tér 1, 4032 Debrecen, Hungary.
- Institute of Gastroenterology, European Reference Network on Hepatological Diseases, ERN RARE-LIVER, Clinical Center, 4032 Debrecen, Hungary.
ORCID-Profile: Zoltán A Mezei, Mária Papp, Éva Csősz, Gergő Kalló
Förderung
- European Union and the Ministry of Hungary
Zitieren
APA
Guba, A., Kováts, P., Mezei, Z. A., Papp, M., Csősz, É., & Kalló, G. (2024). Analysis of Azathioprine Metabolites in Autoimmune Hepatitis Patient Blood—Method Development and Validation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011233
Vancouver
Guba A, Kováts P, Mezei ZA, Papp M, Csősz É, Kalló G. Analysis of Azathioprine Metabolites in Autoimmune Hepatitis Patient Blood—Method Development and Validation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011233
BibTeX
@article{Guba2024,
author = {Guba, Andrea and Kováts, Patrícia and Mezei, Zoltán A and Papp, Mária and Csősz, Éva and Kalló, Gergő},
title = {Analysis of Azathioprine Metabolites in Autoimmune Hepatitis Patient Blood—Method Development and Validation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011233}
}
EUVIMED